The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Voriconazole for Injection Market Research Report 2024

Global Voriconazole for Injection Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1743714

No of Pages : 107

Synopsis
Global Voriconazole for Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Voriconazole for Injection market research.

Key manufacturers engaged in the Voriconazole for Injection industry include Pfizer, Hainan Poly Pharm Co., Ltd., Livzon Pharmaceutical Group Inc., Beijing SL Pharmaceutical Co.,Ltd., Changjiang Runfa Health Industry Co., Ltd., Qilu Antibiotics Pharmaceutical Co., Ltd., Jiangsu Aosaikang Pharmaceutical Co., Ltd., BrightGene Bio-Medical Technology Co., Ltd. and Maithili Life Sciences, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Voriconazole for Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Voriconazole for Injection market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Voriconazole for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Pfizer
  • Hainan Poly Pharm Co., Ltd.
  • Livzon Pharmaceutical Group Inc.
  • Beijing SL Pharmaceutical Co.,Ltd.
  • Changjiang Runfa Health Industry Co., Ltd.
  • Qilu Antibiotics Pharmaceutical Co., Ltd.
  • Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  • BrightGene Bio-Medical Technology Co., Ltd.
  • Maithili Life Sciences
  • Medizia Biotech
  • Criticine Care
  • Eugia US
  • Sandoz Canada
  • Vinson Pharma
  • Alvogen
  • Taj Pharma

Segment by Type

  • Original Drugs
  • Generic Drugs

Segment by Application

  • Hospital
  • Clinic
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Voriconazole for Injection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Voriconazole for Injection Market Overview
1.1 Product Overview and Scope of Voriconazole for Injection
1.2 Voriconazole for Injection Segment by Type
1.2.1 Global Voriconazole for Injection Market Value Comparison by Type (2023-2029)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Voriconazole for Injection Segment by Application
1.3.1 Global Voriconazole for Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Voriconazole for Injection Market Size Estimates and Forecasts
1.4.1 Global Voriconazole for Injection Revenue 2018-2029
1.4.2 Global Voriconazole for Injection Sales 2018-2029
1.4.3 Global Voriconazole for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Voriconazole for Injection Market Competition by Manufacturers
2.1 Global Voriconazole for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Voriconazole for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Voriconazole for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Voriconazole for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Voriconazole for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Voriconazole for Injection, Product Type & Application
2.7 Voriconazole for Injection Market Competitive Situation and Trends
2.7.1 Voriconazole for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Voriconazole for Injection Players Market Share by Revenue
2.7.3 Global Voriconazole for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Voriconazole for Injection Retrospective Market Scenario by Region
3.1 Global Voriconazole for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Voriconazole for Injection Global Voriconazole for Injection Sales by Region: 2018-2029
3.2.1 Global Voriconazole for Injection Sales by Region: 2018-2023
3.2.2 Global Voriconazole for Injection Sales by Region: 2024-2029
3.3 Global Voriconazole for Injection Global Voriconazole for Injection Revenue by Region: 2018-2029
3.3.1 Global Voriconazole for Injection Revenue by Region: 2018-2023
3.3.2 Global Voriconazole for Injection Revenue by Region: 2024-2029
3.4 North America Voriconazole for Injection Market Facts & Figures by Country
3.4.1 North America Voriconazole for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Voriconazole for Injection Sales by Country (2018-2029)
3.4.3 North America Voriconazole for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Voriconazole for Injection Market Facts & Figures by Country
3.5.1 Europe Voriconazole for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Voriconazole for Injection Sales by Country (2018-2029)
3.5.3 Europe Voriconazole for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Voriconazole for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Voriconazole for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Voriconazole for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Voriconazole for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Voriconazole for Injection Market Facts & Figures by Country
3.7.1 Latin America Voriconazole for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Voriconazole for Injection Sales by Country (2018-2029)
3.7.3 Latin America Voriconazole for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Voriconazole for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Voriconazole for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Voriconazole for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Voriconazole for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Voriconazole for Injection Sales by Type (2018-2029)
4.1.1 Global Voriconazole for Injection Sales by Type (2018-2023)
4.1.2 Global Voriconazole for Injection Sales by Type (2024-2029)
4.1.3 Global Voriconazole for Injection Sales Market Share by Type (2018-2029)
4.2 Global Voriconazole for Injection Revenue by Type (2018-2029)
4.2.1 Global Voriconazole for Injection Revenue by Type (2018-2023)
4.2.2 Global Voriconazole for Injection Revenue by Type (2024-2029)
4.2.3 Global Voriconazole for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Voriconazole for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Voriconazole for Injection Sales by Application (2018-2029)
5.1.1 Global Voriconazole for Injection Sales by Application (2018-2023)
5.1.2 Global Voriconazole for Injection Sales by Application (2024-2029)
5.1.3 Global Voriconazole for Injection Sales Market Share by Application (2018-2029)
5.2 Global Voriconazole for Injection Revenue by Application (2018-2029)
5.2.1 Global Voriconazole for Injection Revenue by Application (2018-2023)
5.2.2 Global Voriconazole for Injection Revenue by Application (2024-2029)
5.2.3 Global Voriconazole for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Voriconazole for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Voriconazole for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Hainan Poly Pharm Co., Ltd.
6.2.1 Hainan Poly Pharm Co., Ltd. Corporation Information
6.2.2 Hainan Poly Pharm Co., Ltd. Description and Business Overview
6.2.3 Hainan Poly Pharm Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Hainan Poly Pharm Co., Ltd. Voriconazole for Injection Product Portfolio
6.2.5 Hainan Poly Pharm Co., Ltd. Recent Developments/Updates
6.3 Livzon Pharmaceutical Group Inc.
6.3.1 Livzon Pharmaceutical Group Inc. Corporation Information
6.3.2 Livzon Pharmaceutical Group Inc. Description and Business Overview
6.3.3 Livzon Pharmaceutical Group Inc. Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Livzon Pharmaceutical Group Inc. Voriconazole for Injection Product Portfolio
6.3.5 Livzon Pharmaceutical Group Inc. Recent Developments/Updates
6.4 Beijing SL Pharmaceutical Co.,Ltd.
6.4.1 Beijing SL Pharmaceutical Co.,Ltd. Corporation Information
6.4.2 Beijing SL Pharmaceutical Co.,Ltd. Description and Business Overview
6.4.3 Beijing SL Pharmaceutical Co.,Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Beijing SL Pharmaceutical Co.,Ltd. Voriconazole for Injection Product Portfolio
6.4.5 Beijing SL Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.5 Changjiang Runfa Health Industry Co., Ltd.
6.5.1 Changjiang Runfa Health Industry Co., Ltd. Corporation Information
6.5.2 Changjiang Runfa Health Industry Co., Ltd. Description and Business Overview
6.5.3 Changjiang Runfa Health Industry Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Changjiang Runfa Health Industry Co., Ltd. Voriconazole for Injection Product Portfolio
6.5.5 Changjiang Runfa Health Industry Co., Ltd. Recent Developments/Updates
6.6 Qilu Antibiotics Pharmaceutical Co., Ltd.
6.6.1 Qilu Antibiotics Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Qilu Antibiotics Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Qilu Antibiotics Pharmaceutical Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Qilu Antibiotics Pharmaceutical Co., Ltd. Voriconazole for Injection Product Portfolio
6.6.5 Qilu Antibiotics Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
6.6.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Voriconazole for Injection Product Portfolio
6.7.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 BrightGene Bio-Medical Technology Co., Ltd.
6.8.1 BrightGene Bio-Medical Technology Co., Ltd. Corporation Information
6.8.2 BrightGene Bio-Medical Technology Co., Ltd. Description and Business Overview
6.8.3 BrightGene Bio-Medical Technology Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 BrightGene Bio-Medical Technology Co., Ltd. Voriconazole for Injection Product Portfolio
6.8.5 BrightGene Bio-Medical Technology Co., Ltd. Recent Developments/Updates
6.9 Maithili Life Sciences
6.9.1 Maithili Life Sciences Corporation Information
6.9.2 Maithili Life Sciences Description and Business Overview
6.9.3 Maithili Life Sciences Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Maithili Life Sciences Voriconazole for Injection Product Portfolio
6.9.5 Maithili Life Sciences Recent Developments/Updates
6.10 Medizia Biotech
6.10.1 Medizia Biotech Corporation Information
6.10.2 Medizia Biotech Description and Business Overview
6.10.3 Medizia Biotech Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medizia Biotech Voriconazole for Injection Product Portfolio
6.10.5 Medizia Biotech Recent Developments/Updates
6.11 Criticine Care
6.11.1 Criticine Care Corporation Information
6.11.2 Criticine Care Voriconazole for Injection Description and Business Overview
6.11.3 Criticine Care Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Criticine Care Voriconazole for Injection Product Portfolio
6.11.5 Criticine Care Recent Developments/Updates
6.12 Eugia US
6.12.1 Eugia US Corporation Information
6.12.2 Eugia US Voriconazole for Injection Description and Business Overview
6.12.3 Eugia US Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Eugia US Voriconazole for Injection Product Portfolio
6.12.5 Eugia US Recent Developments/Updates
6.13 Sandoz Canada
6.13.1 Sandoz Canada Corporation Information
6.13.2 Sandoz Canada Voriconazole for Injection Description and Business Overview
6.13.3 Sandoz Canada Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sandoz Canada Voriconazole for Injection Product Portfolio
6.13.5 Sandoz Canada Recent Developments/Updates
6.14 Vinson Pharma
6.14.1 Vinson Pharma Corporation Information
6.14.2 Vinson Pharma Voriconazole for Injection Description and Business Overview
6.14.3 Vinson Pharma Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Vinson Pharma Voriconazole for Injection Product Portfolio
6.14.5 Vinson Pharma Recent Developments/Updates
6.15 Alvogen
6.15.1 Alvogen Corporation Information
6.15.2 Alvogen Voriconazole for Injection Description and Business Overview
6.15.3 Alvogen Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Alvogen Voriconazole for Injection Product Portfolio
6.15.5 Alvogen Recent Developments/Updates
6.16 Taj Pharma
6.16.1 Taj Pharma Corporation Information
6.16.2 Taj Pharma Voriconazole for Injection Description and Business Overview
6.16.3 Taj Pharma Voriconazole for Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Taj Pharma Voriconazole for Injection Product Portfolio
6.16.5 Taj Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Voriconazole for Injection Industry Chain Analysis
7.2 Voriconazole for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Voriconazole for Injection Production Mode & Process
7.4 Voriconazole for Injection Sales and Marketing
7.4.1 Voriconazole for Injection Sales Channels
7.4.2 Voriconazole for Injection Distributors
7.5 Voriconazole for Injection Customers
8 Voriconazole for Injection Market Dynamics
8.1 Voriconazole for Injection Industry Trends
8.2 Voriconazole for Injection Market Drivers
8.3 Voriconazole for Injection Market Challenges
8.4 Voriconazole for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’